Completed PHASE4 INTERVENTIONAL NCT00117130
Study to Evaluate Effectiveness of Aranesp®
Aranesp® Monthly Preference Study
Sponsor: Amgen
Conditions
Kidney Disease
Interventions
Aranesp®
Updated 5 times since 2017 Last updated: Jan 20, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Kidney Disease, this trial is completed. The trial is conducted by Amgen and has accumulated 5 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Amgen
Data source: Amgen
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.